HC
GILD icon

Hendley & Co’s Gilead Sciences GILD Stock Holding History

Hendley & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,072
Closed -$296K – 68
2021
Q4 		$296K Sell
4,072
-545
-12% -$37.5K 0.1% 65
2021
Q3 		$322K Hold
4,617
– – 0.11% 66
2021
Q2 		$318K Sell
4,617
-505
-10% -$33.7K 0.11% 64
2021
Q1 		$331K Sell
5,122
-365
-7% -$23.5K 0.12% 65
2020
Q4 		$320K Sell
5,487
-5,540
-50% -$334K 0.12% 61
2020
Q3 		$697K Sell
11,027
-400
-4% -$27.7K 0.29% 48
2020
Q2 		$879K Sell
11,427
-325
-3% -$24.9K 0.42% 44
2020
Q1 		$879K Sell
11,752
-114
-1% -$7.88K 0.49% 44
2019
Q4 		$771K Sell
11,866
-815
-6% -$53.1K 0.34% 50
2019
Q3 		$804K Sell
12,681
-515
-4% -$33.7K 0.39% 49
2019
Q2 		$892K Buy
13,196
+242
+2% +$15.9K 0.42% 46
2019
Q1 		$842K Sell
12,954
-450
-3% -$29.9K 0.43% 43
2018
Q4 		$838K Sell
13,404
-9,235
-41% -$645K 0.49% 39
2018
Q3 		$1.75M Sell
22,639
-195
-0.9% -$14.7K 0.86% 36
2018
Q2 		$1.62M Sell
22,834
-270
-1% -$19.1K 0.87% 38
2018
Q1 		$1.74M Sell
23,104
-740
-3% -$58.8K 0.92% 37
2017
Q4 		$1.71M Sell
23,844
-1,535
-6% -$117K 0.87% 35
2017
Q3 		$2.06M Sell
25,379
-1,307
-5% -$99.9K 1.12% 34
2017
Q2 		$1.89M Sell
26,686
-195
-0.7% -$13K 1.05% 33
2017
Q1 		$1.83M Sell
26,881
-35
-0.1% -$2.46K 1.09% 30
2016
Q4 		$1.93M Buy
26,916
+1,961
+8% +$146K 1.21% 33
2016
Q3 		$1.97M Sell
24,955
-645
-3% -$52.4K 1.24% 31
2016
Q2 		$2.14M Sell
25,600
-275
-1% -$24.4K 1.31% 32
2016
Q1 		$2.38M Sell
25,875
-60
-0.2% -$5.41K 1.48% 29
2015
Q4 		$2.62M Sell
25,935
-95
-0.4% -$9.88K 1.7% 23
2015
Q3 		$2.56M Buy
26,030
+145
+0.6% +$16.1K 1.74% 22
2015
Q2 		$3.03M Sell
25,885
-75
-0.3% -$8.2K 1.88% 19
2015
Q1 		$2.55M Buy
+25,960
New +$2.64M 1.53% 25

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hendley & Co's GILD Position: Q1 2022 in Review

Hendley & Co sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 4,072 shares — an estimated $296K sold.

Hendley & Co first reported a position in GILD in Q1 2015 and held it in 28 quarters. The position peaked at $3.03M in Q2 2015. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Hendley & Co reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Hendley & Co sold 4,072 Gilead Sciences shares in Q1 2022, an estimated $296K.
  • Hendley & Co first reported a position in Gilead Sciences in Q1 2015 and held it in 28 quarters.
  • Hendley & Co's Gilead Sciences position peaked at $3.03M in Q2 2015.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Hendley & Co's 13F filing for Q1 2022, filed 29 Apr 2022.